BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity with Possible Nootropic Effects Similar to That of LSD Without Hallucinogenic Side Effects
Ryan Allway August 25th, 2022 Psychedelics, Top News VANCOUVER, British Columbia, Aug. 24, 2022 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), is an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders. ​... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )